UPDATE 1-FDA approves Flexion's knee pain drug, shares surge
October 06, 2017 at 15:24 PM EDT
Oct 6 (Reuters) - Flexion Therapeutics Inc said on Friday the U.S. Food and Drug Administration approved its injectable drug, Zilretta, to treat moderate-to-severe osteoarthritis-related knee pain, sending its shares soaring 18 percent.
